Association of SIRT1 single gene nucleotide polymorphisms and serum SIRT1 levels with laryngeal squamous cell carcinoma patient survival rate.
SIRT serum level
SIRT1
five-year survival rate
laryngeal cancer
Journal
Cancer biomarkers : section A of Disease markers
ISSN: 1875-8592
Titre abrégé: Cancer Biomark
Pays: Netherlands
ID NLM: 101256509
Informations de publication
Date de publication:
2022
2022
Historique:
pubmed:
2
11
2021
medline:
3
6
2022
entrez:
1
11
2021
Statut:
ppublish
Résumé
SIRT1 is a multifunctional protein, possibly essential in tumorigenesis pathways, which can act both as a tumor promoter and tumor suppressor depending on the oncogenes, specific to particular tumors. Pathogenesis of laryngeal cancer is multifactorial and the association of SIRT1 expression with the clinical characteristics and prognosis of LSCC has not been fully identified. The study aimed to evaluate associations between single gene nucleotide polymorphisms (SNPs) of SIRT1 (rs3818292, rs3758391, and rs7895833), serum SIRT1 levels, and 5-year survival rate in patients with laryngeal squamous cell carcinoma (LSCC). The study involved 302 patients with LSCC and 409 healthy control subjects. The genotyping of SNPs was performed using RT-PCR, and serum SIRT1 levels were determined by the ELISA method. Our study found significant differences in genotype distributions of SIRT1 rs3758391 polymorphisms between the study groups. SIRT1 rs3758391 T/T genotype was associated with the increased LSCC development odds (OR = 1.960 95% CI = 1.028-3.737; p= 0.041). Carriers of SIRT1 rs3758391 T/T genotype had statistically significantly increased odds of LSCC development into advanced stages under the codominant and recessive genetic models (OR = 2.387 95% CI = 1.091-5.222; p= 0.029 and OR = 2.287 95% CI = 1.070-4.888; p= 0.033, respectively). There were no statistically significant differences in serum SIRT1 levels between the LSCC and control groups. However, LSCC patients with SIRT1 rs3818292 AG genotype demonstrated a tendency to significantly lower SIRT1 serum levels than controls (p= 0.034). No statistically significant associations between SIRT1 (rs3818292, rs3758391, and rs7895833) SNPs and the 5-year survival rate of LSCC patients were found. The present study indicated a statistically significant association between the SIRT1 rs3758391 T/T genotype and increased LSCC development odds. LSCC patients with SIRT1 rs3818292 AG genotype showed a tendency to manifest with lower SIRT1 serum levels. No associations between SIRT1 SNPs and the 5-year survival rate of LSCC patients were detected.
Sections du résumé
BACKGROUND
BACKGROUND
SIRT1 is a multifunctional protein, possibly essential in tumorigenesis pathways, which can act both as a tumor promoter and tumor suppressor depending on the oncogenes, specific to particular tumors. Pathogenesis of laryngeal cancer is multifactorial and the association of SIRT1 expression with the clinical characteristics and prognosis of LSCC has not been fully identified.
OBJECTIVES
OBJECTIVE
The study aimed to evaluate associations between single gene nucleotide polymorphisms (SNPs) of SIRT1 (rs3818292, rs3758391, and rs7895833), serum SIRT1 levels, and 5-year survival rate in patients with laryngeal squamous cell carcinoma (LSCC).
METHODS
METHODS
The study involved 302 patients with LSCC and 409 healthy control subjects. The genotyping of SNPs was performed using RT-PCR, and serum SIRT1 levels were determined by the ELISA method.
RESULTS
RESULTS
Our study found significant differences in genotype distributions of SIRT1 rs3758391 polymorphisms between the study groups. SIRT1 rs3758391 T/T genotype was associated with the increased LSCC development odds (OR = 1.960 95% CI = 1.028-3.737; p= 0.041). Carriers of SIRT1 rs3758391 T/T genotype had statistically significantly increased odds of LSCC development into advanced stages under the codominant and recessive genetic models (OR = 2.387 95% CI = 1.091-5.222; p= 0.029 and OR = 2.287 95% CI = 1.070-4.888; p= 0.033, respectively). There were no statistically significant differences in serum SIRT1 levels between the LSCC and control groups. However, LSCC patients with SIRT1 rs3818292 AG genotype demonstrated a tendency to significantly lower SIRT1 serum levels than controls (p= 0.034). No statistically significant associations between SIRT1 (rs3818292, rs3758391, and rs7895833) SNPs and the 5-year survival rate of LSCC patients were found.
CONCLUSION
CONCLUSIONS
The present study indicated a statistically significant association between the SIRT1 rs3758391 T/T genotype and increased LSCC development odds. LSCC patients with SIRT1 rs3818292 AG genotype showed a tendency to manifest with lower SIRT1 serum levels. No associations between SIRT1 SNPs and the 5-year survival rate of LSCC patients were detected.
Identifiants
pubmed: 34719479
pii: CBM210264
doi: 10.3233/CBM-210264
pmc: PMC9198736
doi:
Substances chimiques
Nucleotides
0
SIRT1 protein, human
EC 3.5.1.-
Sirtuin 1
EC 3.5.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
175-188Références
J Nutrigenet Nutrigenomics. 2016;9(5-6):265-275
pubmed: 28118644
Front Physiol. 2018 Aug 21;9:1030
pubmed: 30246793
Clin Exp Nephrol. 2011 Jun;15(3):381-390
pubmed: 21331741
Eur J Cancer. 2015 Oct;51(15):2130-2143
pubmed: 26421817
Crit Rev Oncog. 2015;20(1-2):49-64
pubmed: 25746104
Sci Rep. 2016 Oct 26;6:35998
pubmed: 27782173
Sci Rep. 2017 Aug 31;7(1):10285
pubmed: 28860538
PLoS One. 2021 Jan 28;16(1):e0243745
pubmed: 33507936
Biochem Genet. 2020 Apr;58(2):213-244
pubmed: 31712935
Cancer Causes Control. 2016 Aug;27(8):1027-34
pubmed: 27379989
Acta Otorhinolaryngol Ital. 2017 Dec;37(6):458-466
pubmed: 28663597
Int J Cancer. 2004 Mar 1;108(6):907-11
pubmed: 14712496
Transl Res. 2011 Jun;157(6):339-47
pubmed: 21575918
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1061-77
pubmed: 16775162
Dis Markers. 2019 Nov 12;2019:3907232
pubmed: 31781300
Eur Arch Otorhinolaryngol. 2016 Jan;273(1):9-20
pubmed: 25311307
Laryngoscope. 2018 Sep;128(9):2039-2053
pubmed: 29508408
Oncotarget. 2017 Jun 15;8(39):66343-66351
pubmed: 29029516
Mol Cancer Ther. 2013 Apr;12(4):499-508
pubmed: 23339189
Oncol Rep. 2017 Jun;37(6):3244-3252
pubmed: 28498463
Mol Biol Rep. 2014 Jul;41(7):4233-9
pubmed: 24570024
Eur J Pharmacol. 2020 Jan 15;867:172847
pubmed: 31812544
J Gerontol A Biol Sci Med Sci. 2007 Sep;62(9):960-5
pubmed: 17895433
PLoS One. 2015 Mar 18;10(3):e0117954
pubmed: 25785999
Front Endocrinol (Lausanne). 2019 Mar 13;10:121
pubmed: 30930849
PLoS One. 2013 Jun 21;8(6):e66975
pubmed: 23805287
Cancer Manag Res. 2017 Sep 04;9:381-386
pubmed: 28919817
Psychiatry Res Neuroimaging. 2020 Jul 30;301:111101
pubmed: 32447184
Chin J Cancer Res. 2020 Feb;32(1):18-25
pubmed: 32194301
Am J Epidemiol. 2006 Aug 15;164(4):367-75
pubmed: 16801374
CA Cancer J Clin. 2017 Jan;67(1):31-50
pubmed: 27898173
Clin Chim Acta. 2010 Nov 11;411(21-22):1679-83
pubmed: 20633545
Rom J Morphol Embryol. 2019;60(2):353-367
pubmed: 31658308
Rep Biochem Mol Biol. 2019 Jul;8(2):194-199
pubmed: 31832445
Nat Cell Biol. 2020 Oct;22(10):1170-1179
pubmed: 32989246
Sci Rep. 2018 Nov 8;8(1):16540
pubmed: 30410074
Am J Ind Med. 2011 Jul;54(7):510-4
pubmed: 21538446
Hum Genet. 2008 Nov;124(4):431-6
pubmed: 18820948
Am J Ind Med. 2008 Sep;51(9):648-55
pubmed: 18626911
Int J Cancer. 2005 Sep 1;116(3):451-7
pubmed: 15810012
J Chin Med Assoc. 2018 May;81(5):416-422
pubmed: 29050728
Nat Commun. 2020 Jun 4;11(1):2814
pubmed: 32499508
Sci Rep. 2018 Sep 18;8(1):13972
pubmed: 30228292
PLoS One. 2016 Mar 21;11(3):e0151901
pubmed: 26999517
Exp Cell Res. 2018 Jun 1;367(1):1-6
pubmed: 29574020
Antioxid Redox Signal. 2018 Mar 10;28(8):711-732
pubmed: 28661724
R Soc Open Sci. 2018 Jun 13;5(6):171871
pubmed: 30110438
Cancer Cell Int. 2018 Oct 22;18:163
pubmed: 30377410
Laryngoscope. 2017 Jan;127(1):127-133
pubmed: 27392821
Br J Cancer. 2020 Oct;123(9):1456-1463
pubmed: 32830199
PLoS One. 2012;7(11):e48621
pubmed: 23133645
J Neurosci. 2013 May 15;33(20):8621-32
pubmed: 23678107
J Gerontol A Biol Sci Med Sci. 2017 Jul 1;72(7):870-876
pubmed: 28329314
Mini Rev Med Chem. 2009 Mar;9(3):386-94
pubmed: 19275731
Neurosci Bull. 2018 Oct;34(5):863-866
pubmed: 29786760
Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Mar;115(3):385-92
pubmed: 23453030
Int J Mol Epidemiol Genet. 2010 Jun 20;1(3):214-25
pubmed: 21537393